ECDC expresses concern on antibiotics overuse; will warn doctors

11 November 2009

The prescription of antibiotics, even when they are not required, is fuelling a rise in number of infections that are resistant to antibiotics, said experts at European Centre of Disease prevention and Control (ECDC) in Stockholm. The ECDC intervention comes after several previous warnings about antibiotic use, and coincides with a UK report drawing similar conclusions

Sarah Earnshaw, an expert at ECDC said that patients, especially parents are often demanding antibiotics for their children. A survey in 2002 showed that 60% of people did not know that antibiotics do not work against viruses such as flu.

The ECDC will be writing to all general physicians warning them about overuse of the drugs and giving them materials to help them explain to demanding patients that antibiotics must be used sparingly, she added.

Modern medicine under threat

The whole span of modern medicine is under threat because antibiotics are being overused, warned Dominique Monnet, a senior expert at the scientific advice unit at the ECDC. 'Organ transplants, hip replacements, cancer chemotherapy, intensive care and neonatal care for premature babies, all of which need antibiotics to prevent bacterial infection, will no longer be possible if we lose it with antibiotics,' according to Ms Monnet.

In a statement, the ECDC said that, 'since their discovery, antibiotics have revolutionized the way we treat patients with bacterial infections and have contributed to reducing the mortality and morbidity from bacterial diseases. They are also an essential tool for modern medicine and common procedures such as transplants, chemotherapy for cancer and even orthopedic surgery could not be performed without the availability of potent antibiotics.

It added: 'Unfortunately antibiotics have also been liable to misuse. Antibiotics are often unnecessarily prescribed for viral infections, against which they have no effect. Similarly when diagnoses are not accurately made, more often than not, broad-spectrum antibiotics, i.e. antibiotics that kill a large proportion of various bacteria and not only the bacteria responsible for the disease, are prescribed because the micro-organism responsible for the infection is not known. These examples of misuse promote the emergence and the selection of resistant bacteria.'

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical